Neumol Pediatr 2022; 17 (3): 103 - 106 Revista Neumología Pediátrica | Contenido disponible en www.neumologia-pediatrica.cl 106 Tuberculosis miliar en pecientes en tratamiento con adalimumab, una asociación no tan frecuente en pediatría 1. Thomas TA. Tuberculosis in Children. Pediatr Clin North Am. 2017 Aug;64(4):893-909. doi: 10.1016/j.pcl.2017.03.010. h t t ps : //www . ncb i . n lm. n i h . gov/pmc /a r t i c les / PMC5555046/ 2. Toussi SS, Pan N, Walters HM, Walsh TJ. Infections in children and adolescents with juvenile idiopathic arthritis and inflammatory bowel disease treated with tumor necrosis factor-α inhibitors: systematic review of the literature. Clin Infect Dis. 2013 Nov;57(9):1318-30. doi: 10.1093/cid/ cit489. https://pubmed.ncbi.nlm.nih.gov/23899685/ 3. Hehlgans T, Pfeffer K. The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games. Immunology. 2005 May;115(1):1-20. doi: 10.1111/j.1365-2567.2005.02143.x. https://pubmed.ncbi.nlm.nih.gov/15819693/ 4. Gardam MA, Keystone EC, Menzies R, Manners S, Skamene E, Long R, Vinh DC. Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management. Lancet Infect Dis. 2003Mar;3(3):148-55. doi: 10.1016/s1473-3099(03)00545-0. https://pubmed.ncbi. nlm.nih.gov/12614731/ 5. Resolución 227 de 2020. Lineamientos técnicos y operativos del programa nacional de prevención y control de la tuberculosis. Ministerio de Salud y Protección Social [internet]. Colombia: Ministerio de Salud y Protección social;c2020 [citada 01 Jun 2022]. Disponible en:https:// www.minsalud.gov.co/Normatividad_Nuevo/Resoluci%- C3%B3n%20No.%20227%20de%202020.pdf 6. WHO consolidated guidelines on tuberculosis: tuberculosis preventive treatment: Module 1: prevention [Internet]. Geneva: World Health Organization; 2020 [cited 2022 Jun 01]. Available:https://www.ncbi.nlm.nih.gov/books/ NBK554956/ 7. Sterling TR, Njie G, Zenner D, Cohn DL, Reves R, Ahmed A, et al. Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020. MMWR Recomm Rep. 2020 Feb 14;69(1):1-11. doi: 10.15585/mmwr.rr6901a1. https://pubmed.ncbi.nlm.nih.gov/32053584/ 8. American Academy of Pediatrics. Red Book: 2021-2024 Report of the Committee on Infectious Diseases, 32 ed, Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH (Eds), American Academy of Pediatrics, Itasca, IL 2021. 9. Noguera-Julián A, Calzada-Hernández J, Brinkmann F et al. Tuberculosis Disease in Children and Adolescents on Therapy With Antitumor Necrosis Factor-ɑ Agents: A Collaborative, Multicenter Paediatric Tuberculosis Network European Trials Group (ptbnet) Study. Clin Infect Dis. 2020 Dec 17;71(10):2561-2569. doi: 10.1093/cid/ciz1138. https:// pubmed.ncbi.nlm.nih.gov/31796965/ 10. Schick B, Dolgin J. The influence of prednisone on the Mantoux reaction in children. Pediatrics. 1963;31:856–859. https://pubmed.ncbi.nlm.nih.gov/13991653/ 11. Redelman-Sidi G, Sepkowitz KA. IFN-γ release assays in the diagnosis of latent tuberculosis infection among immunocompromised adults. Am J Respir Crit Care Med. 2013 Aug 15;188(4):422-31. doi: 10.1164/rccm.201209-1621CI. https://pubmed.ncbi.nlm.nih.gov/23262514/ 12. Ardura MI, Toussi SS, Siegel JD, Lu Y, Bousvaros A, Crandall W. NASPGHAN Clinical Report: Surveillance, Diagnosis, and Prevention of Infectious Diseases in Pediatric Patients with Inflammatory Bowel Disease Receiving Tumor Necrosis Factor-α Inhibitors. J Pediatr Gastroenterol Nutr. 2016 jul;63(1):130-55. doi: 10.1097/MPG.0000000000001188. https://pubmed.ncbi.nlm.nih.gov/27027903/ 13. Winthrop KL, Baxter R, Liu L, Varley CD, Curtis JR, Baddley JW, et al. Mycobacterial diseases and antitumour necrosis factor therapy inUSA. Ann RheumDis. 2013 Jan;72(1):37-42. doi: 10.1136/annrheumdis-2011-200690. https://pubmed.ncbi.nlm.nih.gov/22523429/ 14. Hess S, Hospach T, Nossal R, Dannecker G, Magdorf K, Uhlemann F. Life-threatening disseminated tuberculosis as a complication of TNF-α blockade in an adolescent. Eur J Pediatr. 2011 Oct;170(10):1337-42. doi: 10.1007/s00431011-1501-y. https://pubmed.ncbi.nlm.nih.gov/21625932/ REFERENCIAS
RkJQdWJsaXNoZXIy MTYwMjk1